Literature DB >> 8789857

Subretinal bleeding without choroidal neovascularization in pathologic myopia. A sign of new lacquer crack formation.

K Ohno-Matsui1, M Ito, T Tokoro.   

Abstract

PURPOSE: The clinical significance of subretinal bleeding without choroidal neovascularization in pathologic myopia is unclear. Only two reports in the ophthalmic literature have demonstrated the clinical course of subretinal bleeding and have indicated that it might be a precursor of lacquer cracks. In this study, the authors observed the clinical course of subretinal bleeding in highly myopic eyes and studied this condition in relation to new lacquer crack formation.
METHODS: The authors examined consecutively and prospectively 22 highly myopic eyes (19 patients) with subretinal bleeding. Indirect ophthalmoscopy and fluorescein fundus angiography were performed in all patients. Indocyanine green (ICG) angiography could be performed in three patients. The follow-up period ranged from 6 to 198 months (mean, 61.3 months).
RESULTS: In 17 of 22 eyes, lacquer cracks appeared at the site of previous subretinal bleeding. The period for the formation of new lacquer cracks after the onset of the bleeding ranged from 2 to 6 months (mean, 4.0 months). In one patient, ICG angiography revealed linear hypofluorescence, indicating a ruptured Bruch's membrane at the onset of subretinal bleeding.
CONCLUSION: A rupture of Bruch's membrane and choriocapillaris complex results in subretinal bleeding, which is the first process of new lacquer crack formation. Atrophy of the overlying pigment epithelium and further scar formation results in the development of a lacquer crack.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8789857     DOI: 10.1097/00006982-199616030-00003

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  11 in total

1.  Multimodal imaging including spectral-domain optical coherence tomography and confocal near-infrared reflectance for characterization of lacquer cracks in highly myopic eyes.

Authors:  C-F Liu; L Liu; C-C Lai; J Cl Chou; L-K Yeh; K-J Chen; Y-P Chen; W-C Wu; L-H Chuang; C-C Sun; N-K Wang
Journal:  Eye (Lond)       Date:  2014-09-19       Impact factor: 3.775

Review 2.  [Epidemiology and anatomy of myopia].

Authors:  Jost B Jonas; Songhomitra Panda-Jonas
Journal:  Ophthalmologe       Date:  2019-06       Impact factor: 1.059

Review 3.  Management of Myopic Choroidal Neovascularization: Focus on Anti-VEGF Therapy.

Authors:  Kelvin Yi Chong Teo; Wei Yan Ng; Shu Yen Lee; Chui Ming Gemmy Cheung
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

Review 4.  Insight into high myopia and the macula.

Authors:  Atul Kumar; Rohan Chawla; Devesh Kumawat; Ganesh Pillay
Journal:  Indian J Ophthalmol       Date:  2017-02       Impact factor: 1.848

5.  Immediate post partum macular subretinal bleeding in a highly myopic patient: a case report.

Authors:  Karen Bitton; J-L Bacquet; F Amoroso; S Mrejen; M Paques; E H Souied
Journal:  BMC Ophthalmol       Date:  2021-01-21       Impact factor: 2.209

6.  Clinical characteristics and visual outcome of macular hemorrhage in pathological myopia with or without choroidal neovascularization.

Authors:  Kuei-Jung Chang; Cheng-Kuo Cheng; Chi-Hsien Peng
Journal:  Taiwan J Ophthalmol       Date:  2016-06-24

7.  Lacquer cracks observed in peripheral fundus of eyes with high myopia.

Authors:  Mitsuki Suga; Kosei Shinohara; Kyoko Ohno-Matsui
Journal:  Int Med Case Rep J       Date:  2017-04-10

8.  Long-Term Natural Outcomes of Simple Hemorrhage Associated with Lacquer Crack in High Myopia: A Risk Factor for Myopic CNV?

Authors:  Bing Liu; Xiongze Zhang; Lan Mi; Ling Chen; Feng Wen
Journal:  J Ophthalmol       Date:  2018-01-24       Impact factor: 1.909

9.  Fluorescein Leakage within Recent Subretinal Hemorrhage in Pathologic Myopia: Suggestive of CNV?

Authors:  Lan Mi; Chengguo Zuo; Xiongze Zhang; Bing Liu; Yuting Peng; Feng Wen
Journal:  J Ophthalmol       Date:  2018-08-13       Impact factor: 1.909

10.  Preclinical Evaluation of a Cell-Based Gene Therapy Using the Sleeping Beauty Transposon System in Choroidal Neovascularization.

Authors:  Maria Hernandez; Sergio Recalde; Laura Garcia-Garcia; Jaione Bezunartea; Csaba Miskey; Sandra Johnen; Sabine Diarra; Attila Sebe; Juan Roberto Rodriguez-Madoz; Severine Pouillot; Corinne Marie; Zsuzsanna Izsvák; Daniel Scherman; Martina Kropp; Felipe Prosper; Gabriele Thumann; Zoltán Ivics; Alfredo Garcia-Layana; Patricia Fernandez-Robredo
Journal:  Mol Ther Methods Clin Dev       Date:  2019-11-09       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.